Listar por autor "D'Amico, Francesco"
Mostrando ítems 1-2 de 2
-
Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial
Luciano, Juan V; D'Amico, Francesco; Cerdà-Lafont, Marta; Peñarrubia-María, María T; Knapp, Martin; Cuesta-Vargas, Antonio
; Serrano-Blanco, Antoni; Garcia Campayo, Javier[et al.] (BMC Springer Nature, 2014-10-01)
Introduction: Cognitive behavioral therapy (CBT) and U.S. Food and Drug Administration (FDA)-recommended pharmacologic treatments (RPTs; pregabalin, duloxetine, and milnacipran) are effective treatment options for fibromyalgia ... -
Efficacy, cost-utility and physiological effects of Acceptance and Commitment Therapy (ACT) and Behavioural Activation Treatment for Depression (BATD) in patients with chronic low back pain and depression: study protocol of a randomised, controlled trial including mobile-technology-based ecological momentary assessment (IMPACT study)
Sanabria-Mazo, Juan P; Forero, Carlos G; Cristobal-Narváez, Paula; Suso-Ribera, Carlos; García-Palacios, Azucena; Colomer-Carbonell, Ariadna; Pérez-Aranda, Adrián; Andrés-Rodríguez, Laura; McCracken, Lance M; D'Amico, Francesco; Estivill-Rodríguez, Pere; Carreras-Marcos, Bernat; Montes-Pérez, Antonio; Comps-Vicente, Olga; Esteve, Montserrat; Grasa, Mar; Rosa, Araceli; Cuesta-Vargas, Antonio; Maes, Michael; Borràs, Xavier; Edo, Silvia; Sanz, Antoni; Feliu-Soler, Albert; Castaño-Asins, Juan R; Luciano, Juan V[et al.] (BMJ Journals, 2020-07-23)
Introduction: The IMPACT study focuses on chronic low back pain (CLBP) and depression symptoms, a prevalent and complex problem that represents a challenge for health professionals. Acceptance and Commitment Therapy (ACT) ...